To validate the CXCL12-induced breast cancer cell migration in vivo MDA-MB-231 cells with shRNA-mediated reduction of CXCR4 (MDA-MB-231-19 and MDA-MB-231-27) were compared with wild-type cells. This evidence concerns the gene CXCR4 and breast cancer.